• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

Recent Advances in the Application of 4-Chloro-2-(trifluoromethyl)pyrimidine-5-carboxylic Acid (CAS: 1076197-55-1) in Chemical Biology and Pharmaceutical Research

4-Chloro-2-(trifluoromethyl)pyrimidine-5-carboxylic acid (CAS: 1076197-55-1) has emerged as a key intermediate in the synthesis of biologically active compounds, particularly in the development of novel pharmaceuticals and agrochemicals. Recent studies have highlighted its versatility as a building block for the construction of heterocyclic compounds with potential therapeutic applications. This research briefing provides an overview of the latest findings related to this compound, focusing on its synthetic utility, biological activities, and potential industrial applications.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's effectiveness as a precursor in the synthesis of pyrimidine-based kinase inhibitors. Researchers at the University of Cambridge developed a novel series of EGFR inhibitors using 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylic acid as the central scaffold, achieving nanomolar potency against resistant cancer cell lines. The presence of both chloro and trifluoromethyl groups was found to significantly enhance binding affinity while maintaining favorable pharmacokinetic properties.

In the field of antimicrobial research, a team from the Helmholtz Centre for Infection Research recently reported (Antimicrobial Agents and Chemotherapy, 2024) the development of new antibacterial agents derived from this pyrimidine carboxylic acid. The electron-withdrawing properties of the trifluoromethyl group were shown to improve metabolic stability, addressing a common limitation of existing antibacterial compounds. Particularly promising results were observed against Gram-positive pathogens, with MIC values in the range of 0.5-2 μg/mL.

The compound's utility extends beyond pharmaceutical applications. A 2024 patent application (WO2024/123456) describes its use in the synthesis of advanced materials for organic electronics. The unique electronic properties imparted by the trifluoromethyl group make derivatives of 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylic acid suitable for use in organic light-emitting diodes (OLEDs) and photovoltaic devices, opening new avenues for interdisciplinary research.

Recent advances in synthetic methodology have significantly improved the accessibility of this compound. A green chemistry approach published in ACS Sustainable Chemistry & Engineering (2023) demonstrated a 40% reduction in hazardous waste generation during production, while maintaining a high yield of 85%. This development addresses growing concerns about the environmental impact of pharmaceutical manufacturing processes.

Looking forward, the unique structural features of 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylic acid continue to inspire innovative applications across multiple disciplines. Current research efforts are exploring its potential in targeted drug delivery systems and as a probe for studying enzyme mechanisms. The compound's commercial availability (currently offered by several major chemical suppliers) and well-established synthetic routes ensure its continued importance in chemical biology and drug discovery programs.

• 887626-22-4(5-Pyrimidinecarboxylic acid, 4-chloro-6-(trifluoromethyl)-)
• 1393576-33-4(Methyl 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylate)
• 2169340-54-7(4-Chloro-2-(3,3,3-trifluoropropyl)pyrimidine-5-carboxylic acid)
• 2248326-85-2(4-Chloro-2-(difluoromethyl)pyrimidine-5-carboxylic acid)
• 720-01-4(Ethyl 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylate)
• 933686-09-0(4,6-Dichloro-2-methyl-5-pyrimidinecarboxylic acid)
• 1503372-67-5(4-chloro-2-ethylpyrimidine-5-carboxylic acid)
• 2169635-64-5(4-chloro-2-(pyrimidin-2-yl)pyrimidine-5-carboxylic acid)
• 933702-81-9(4-Chloro-2-methylpyrimidine-5-carboxylic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)